These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3893688

  • 21. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T, Ishihara T, Campoli M, Ferrone S.
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [Abstract] [Full Text] [Related]

  • 22. Accumulation of gangliosides with N-acetylneuraminosyl(alpha 2-6)lactosamine structure in primary human hepatoma.
    Taki T, Yamamoto K, Takamatsu M, Ishii K, Myoga A, Sekiguchi K, Ikeda I, Kurata K, Nakayama J, Handa S.
    Cancer Res; 1990 Feb 15; 50(4):1284-90. PubMed ID: 2153456
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R, Burg G, Doguoglu A, Ilg EC, Schäfer BW, Müller B, Heizmann CW.
    Br J Dermatol; 1997 Jul 15; 137(1):39-43. PubMed ID: 9274623
    [Abstract] [Full Text] [Related]

  • 24. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA, Marincola FM, Filie A, Hijazi YM, Kleiner DE, Abati A.
    Cancer; 1999 Feb 25; 87(1):37-42. PubMed ID: 10096358
    [Abstract] [Full Text] [Related]

  • 25. Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis.
    Smolle J, Soyer HP, Hofmann-Wellenhof R, Smolle-Juettner FM, Kerl H.
    Pathol Res Pract; 1989 Nov 25; 185(5):740-5. PubMed ID: 2696951
    [Abstract] [Full Text] [Related]

  • 26. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB, Wu D, Ragupathi G, Lu S, Williams L, Hwu WJ, Johnson D, Livingston PO.
    Clin Cancer Res; 2004 Jul 15; 10(14):4717-23. PubMed ID: 15269144
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.
    Khan A, Grammer S, Chang D, Hill NO, Miller J.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5868-72. PubMed ID: 6196109
    [Abstract] [Full Text] [Related]

  • 33. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
    Kornstein MJ, Brooks JS, Elder DE.
    Cancer Res; 1983 Jun 15; 43(6):2749-53. PubMed ID: 6342758
    [Abstract] [Full Text] [Related]

  • 34. Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumors.
    Popa I, Pons A, Mariller C, Tai T, Zanetta JP, Thomas L, Portoukalian J.
    Glycobiology; 2007 Apr 15; 17(4):367-73. PubMed ID: 17242043
    [Abstract] [Full Text] [Related]

  • 35. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL, Beckett ML, Starling JJ, Schellhammer PF, Sieg SM, Ladaga LE, Poleskic S.
    Cancer Res; 1983 Nov 15; 43(11):5509-16. PubMed ID: 6193873
    [Abstract] [Full Text] [Related]

  • 36. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
    Nasi ML, Meyers M, Livingston PO, Houghton AN, Chapman PB.
    Melanoma Res; 1997 Aug 15; 7 Suppl 2():S155-62. PubMed ID: 9578432
    [Abstract] [Full Text] [Related]

  • 37. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bcl-2 expression in human melanocytes and melanocytic tumors.
    van den Oord JJ, Vandeghinste N, De Ley M, De Wolf-Peeters C.
    Am J Pathol; 1994 Aug 15; 145(2):294-300. PubMed ID: 8053490
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.